Ningbo-headquartered biotech company Konfoong Biotech International Co.,Ltd (KFBIO) has announced the completion of as much as 100 million yuan ($14 million) in its Series B round of financing, per a company statement on Thursday. It was led by Intel Capital, an investment vehicle of Intel Corporation focused on emerging technology companies globally.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
